Machine learning insights into early mortality risks for small cell lung cancer patients post-chemotherapy
IntroductionSmall cell lung cancer (SCLC) is a highly aggressive form of lung cancer, and chemotherapy remains a cornerstone of its management. However, the treatment is associated with significant risks, including heightened toxicity and early mortality. This study aimed to quantify the 90-day mort...
Saved in:
Main Authors: | Min Liang, Fuyuan Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1483097/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival outcomes of surgery and adjuvant chemotherapy in early-stage small cell and large cell lung cancer: a novel focus on tumors less than 1 cm
by: Jorge Raul Vazquez-Urrutia, et al.
Published: (2025-01-01) -
Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study
by: Zhi Yang, et al.
Published: (2025-01-01) -
Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
by: Qiong Zhang, et al.
Published: (2025-01-01) -
Clinical Significance of the Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Predicting Chemotherapy Outcomes for Small Cell Lung Cancer
by: Gao L, et al.
Published: (2025-01-01) -
Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
by: Pengliang Xu, et al.
Published: (2025-02-01)